Se. Borst et al., Metformin treatment enhances insulin-stimulated glucose transport in skeletal muscle of Sprague-Dawley rats, LIFE SCI, 67(2), 2000, pp. 165-174
Although the glucose-lowering properties of metformin are well-established,
its effects on glucose metabolism in skeletal muscle have not been clearly
defined. We tested the effects of metformin in young adult male Sprague-Da
wley rats, which have a documented reduced response to insulin in skeletal
muscle. Rats were treated with metformin for 20 days (320 mg/kg/day) in the
drinking water. During this period, metformin completely prevented the inc
rease in food intake and decreased adiposity by 30%. Metformin also reduced
insulin secretion by 37% following an intra-peritoneal injection of glucos
e. Finally, metformin enhanced transport of [H-3]-2-deoxyglucose in isolate
d strips of soleus muscle. Metformin substantially increased insulin-stimul
ated transport, while having no effect on basal transport. In control rats,
a maximal concentration of insulin stimulated transport 77% above basal. I
n metformin-treated rats, insulin stimulated transport 206% above basal. We
conclude that in the Sprague-Dawley rat model, metformin causes a signific
ant increase in insulin-responsiveness. (C) 2000 Elsevier Science Inc. All
rights reserved.